Educational Brochures
This selection of brochures can help you better understand MS and its treatment. Simply click on a title below to download a brochure.
PathfinderSM: Your Life. Your Way.
This brochure provides a comprehensive introduction to MS and to the treatment options available. It can help you to better understand how MS affects the body and to gain an understanding of how to select the treatment that may be best for you.
Download
At the First Sign of Multiple Sclerosis You Can Do Something
This informative booklet contains a wealth of information about BETASERON, as well as explaining why early treatment is so important. In it, you'll learn just why people start with and stay on BETASERON. Download
Multiple Sclerosis: What It's Doing to You and What You Can Do About It.
This straightforward, easy-to-read brochure will help you understand the causes, symptoms, and treatment of MS. It also introduces you to the benefits of BETASERON. This brochure is a great starting point for discussions with your healthcare provider. Download
Free Tele/Webcast Series on Multiple Sclerosis
Throughout the year, MS PathwaysSM offers a range of informative and interactive tele/webcasts on issues that are important to people living with MS. Find descriptions of the presentations scheduled through early 2008 in this handy brochure. Download
You can get more helpful tips and advice from the Support Community
BETASERON® (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Important Safety Information
The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.
